Novartis India

Rediff.com » News » Novartis India

News for Novartis India

Business

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......

Budget 2023: What the pharma, healthcare industry seek

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......

Novartis India bullish on rural sales

Swiss drug major Novartis' Indian arm is upbeat about its rural sales initiative, Arogya Parviar and plans to double its reach in the country over the next few years. "Arogya Parivar that started......

Novartis India FY04 net up 83%

Novartis India Ltd has reported a 83.48 per cent rise in net profit at Rs 113.76 crore (Rs 1,137.6 million) for the fiscal ended March 31, 2004, compared to Rs 62 crore (Rs 620 million) in the......

Court bars Cipla from selling copy of Novartis respiratory drug

The Delhi High Court has barred generic drugmaker Cipla Ltd from making or selling a cheaper copy of Novartis AG's respiratory drug Onbrez domestically, citing infringement of patents......

Rediff News

Novartis India

News for Novartis India

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Budget 2023: What the pharma, healthcare industry seek

Novartis India bullish on rural sales

Novartis India FY04 net up 83%

Court bars Cipla from selling copy of Novartis respiratory drug

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS